Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWCefixime is a cephalosporin antibiotic.1 It is active against numerous Gram-negative bacteria, including clinical isolates of E. coli, K. pneumoniae, and P. mirabilis (MIC90s = 3.13, 0.2, and ≤0.025 µg/ml, respectively), as well as clinical isolates of the Gram-positive bacteria S. pneumoniae and S. pyogenes (MIC90s = 0.2 and 0.39 µg/ml, respectively).2 Cefixime is resistant to hydrolysis by β-lactamases isolated from several bacteria compared to cefaclor (Item No. 23626), cephalexin (Item No. 9002009), or cefradine (Item No. 26060).1 It increases survival in mice infected with E. coli, K. pneumoniae, or P. mirabilis (ED50s = 0.212, 0.132, and 0.349 mg/kg, respectively).2 Formulations containing cefixime have been used in the treatment of bacterial infections.
WARNING This product is not for human or veterinary use.
1. Comparative in vitro activity and β-
2. In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic. Antimicrob. Agents Chemother. 25(1), 98-104 (1984).